Introducing new Head of Research & Development

Since April 1, 2023, Dr. Kai Prager has been joining DiaSys Diagnostic Systems as Head of R&D. Dr. Prager is German citizen and offers more than 15 years of experience in the diagnostic sector. His focus is on developing innovative diagnostic test systems in the field of autoimmune diseases and other disorders, which comprises the whole value chain from biomarker development to the registered IVD product.

His background in biology, biochemistry and cell biology, along with his experience as Senior Manager R&D Autoimmune Diagnostics at AESKU Group will certainly contribute to DiaSys' further success.

In 2022, Professor Matthias Grimmler decided to leave his position at DiaSys, however, within a two years transition period during which he will still take over responsibility for several current DiaSys projects until June 2023, and gradually hand over all responsibilities to Dr. Prager. As of July 2024, Prof. Grimmler will dedicate his time exclusively to the new assignment as Head Customer Business Care and Head New Technologies and Products and as Co-CEO of DiaServe Laboratories. In 2016, DiaSys acquired a participation in DiaServe with regard to producing controls, calibrators, and processed human specimen material.